Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 9 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

Application EP-3633377-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.